These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 10444256)
1. In vitro and in vivo responses of murine granulocytes to human complement-derived, haemolytically inactive C5b67 (iC5b67). Wang C; Bozza PT; Barbashov SF; Sauty A; Nicholson-Weller A Clin Exp Immunol; 1999 Aug; 117(2):261-8. PubMed ID: 10444256 [TBL] [Abstract][Full Text] [Related]
2. Hemolytically inactive C5b67 complex: an agonist of polymorphonuclear leukocytes. Wang C; Barbashov S; Jack RM; Barrett T; Weller PF; Nicholson-Weller A Blood; 1995 May; 85(9):2570-8. PubMed ID: 7727785 [TBL] [Abstract][Full Text] [Related]
3. Signaling by hemolytically inactive C5b67, an agonist of polymorphonuclear leukocytes. Wang C; Gerard NP; Nicholson-Weller A J Immunol; 1996 Jan; 156(2):786-92. PubMed ID: 8543834 [TBL] [Abstract][Full Text] [Related]
4. Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage. Fung M; Lu M; Fure H; Sun W; Sun C; Shi NY; Dou Y; Su J; Swanson X; Mollnes TE Clin Exp Immunol; 2003 Aug; 133(2):160-9. PubMed ID: 12869020 [TBL] [Abstract][Full Text] [Related]
5. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood. Brekke OL; Christiansen D; Fure H; Fung M; Mollnes TE J Leukoc Biol; 2007 Jun; 81(6):1404-13. PubMed ID: 17389579 [TBL] [Abstract][Full Text] [Related]
6. Neutrophil chemotactic activity and C5a following systemic activation of complement in rats. Schmid E; Warner RL; Crouch LD; Friedl HP; Till GO; Hugli TE; Ward PA Inflammation; 1997 Jun; 21(3):325-33. PubMed ID: 9246574 [TBL] [Abstract][Full Text] [Related]
7. Complement activation during blood sampling procedures alters the expression of CD11b/CD18 on human neutrophils. Wehlin L; Gustavsson K; Halldén G; Emilson A; Svensson A; Hild M; Lundahl J Vox Sang; 1998; 74(1):21-6. PubMed ID: 9481856 [TBL] [Abstract][Full Text] [Related]
8. Serum amyloid P component forms a stable complex with human C5b6. Barbashov SF; Wang C; Nicholson-Weller A J Immunol; 1997 Apr; 158(8):3830-5. PubMed ID: 9103450 [TBL] [Abstract][Full Text] [Related]
9. Complement-induced expression of cryptic receptors on the neutrophil surface: a mechanism for regulation of acute inflammation in trauma. Solomkin JS; Cotta LA; Ogle JD; Brodt JK; Ogle CK; Satoh PS; Hurst JM; Alexander JW Surgery; 1984 Aug; 96(2):336-44. PubMed ID: 6087484 [TBL] [Abstract][Full Text] [Related]
10. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b. Rosenfeld SI; Jenkins DE; Leddy JP J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820 [TBL] [Abstract][Full Text] [Related]
11. Transgenic mice expressing rabbit C-reactive protein exhibit diminished chemotactic factor-induced alveolitis. Ahmed N; Thorley R; Xia D; Samols D; Webster RO Am J Respir Crit Care Med; 1996 Mar; 153(3):1141-7. PubMed ID: 8630558 [TBL] [Abstract][Full Text] [Related]
12. Neutrophil maturation and activation determine anatomic site of clearance from circulation. Suratt BT; Young SK; Lieber J; Nick JA; Henson PM; Worthen GS Am J Physiol Lung Cell Mol Physiol; 2001 Oct; 281(4):L913-21. PubMed ID: 11557595 [TBL] [Abstract][Full Text] [Related]
13. C5a-induced chemiluminescence of human granulocytes and its amplification by a serum factor. Maly FE; Kapp A; Rother U Immunobiology; 1983 Feb; 164(1):90-7. PubMed ID: 6303949 [TBL] [Abstract][Full Text] [Related]
14. Terminal complement components play a role in the expression of C5a. Gresham HD; Renfer L; Hammer CH; Frank MM J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718 [TBL] [Abstract][Full Text] [Related]
15. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. DiScipio RG; Daffern PJ; Jagels MA; Broide DH; Sriramarao P J Immunol; 1999 Jan; 162(2):1127-36. PubMed ID: 9916743 [TBL] [Abstract][Full Text] [Related]
16. C5a mediates secretion and activation of matrix metalloproteinase 9 from human eosinophils and neutrophils. DiScipio RG; Schraufstatter IU; Sikora L; Zuraw BL; Sriramarao P Int Immunopharmacol; 2006 Jul; 6(7):1109-18. PubMed ID: 16714214 [TBL] [Abstract][Full Text] [Related]
17. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. Daffern PJ; Pfeifer PH; Ember JA; Hugli TE J Exp Med; 1995 Jun; 181(6):2119-27. PubMed ID: 7760001 [TBL] [Abstract][Full Text] [Related]
18. Human C5a des Arg increases vascular permeability. José PJ; Forrest MJ; Williams TJ J Immunol; 1981 Dec; 127(6):2376-80. PubMed ID: 6170701 [TBL] [Abstract][Full Text] [Related]
19. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. Rot A; Krieger M; Brunner T; Bischoff SC; Schall TJ; Dahinden CA J Exp Med; 1992 Dec; 176(6):1489-95. PubMed ID: 1281207 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of allergen- and LPS-induced bone marrow eosinophil mobilization and eosinophil accumulation into the pleural cavity: a role for CD11b/CD18 complex. Larangeira AP; Silva AR; Gomes RN; Penido C; Henriques MG; Castro-Faria-Neto HC; Bozza PT Inflamm Res; 2001 Jun; 50(6):309-16. PubMed ID: 11475332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]